D. E. Shaw & Co., Inc. DICERNA PHARMACEUTICALS INC Transaction History

D. E. Shaw & Co., Inc.

  • $107 Billion
  • Q3 2024

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
N/A
-103,422 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
N/A
103,422 New
103,422 $2.09 Million
Q2 2021

Aug 16, 2021
SELL
N/A
-27,090 Closed
0 $0
Q1 2021

May 17, 2021
SELL
N/A
-88,755 Reduced 76.62%
27,090 $693,000
Q4 2020

Feb 16, 2021
SELL
N/A
-15,078 Reduced 11.52%
115,845 $2.55 Million
Q3 2020

Nov 16, 2020
SELL
N/A
-20,894 Reduced 13.76%
130,923 $2.36 Million
Q2 2020

Aug 14, 2020
SELL
N/A
-9,032 Reduced 5.62%
151,817 $3.86 Million
Q1 2020

May 15, 2020
BUY
N/A
41,579 Added 34.86%
160,849 $2.96 Million
Q4 2019

Feb 14, 2020
BUY
N/A
97,733 Added 453.79%
119,270 $2.63 Million
Q3 2019

Nov 14, 2019
BUY
N/A
21,537 New
21,537 $309,000
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email